glp-1 news today nov 2025 Novo Nordisk cuts forecast amid slower sales π½οΈ As more people adopt
Description
How oculoplastic surgeons are rejuvenating faces.
GLP-1 Patent Expiry: The Next Big Pharma Race Has Already Begun GLP-1 agonists like semaglutide, tirzepatide, and liraglutide have completely reshaped the global diabetes and obesity landscape
In another huge manufacturing outlay, Eli Lilly sets aside $1.2 billion for upgrades in Puerto Rico where it will make its new oral GLP-1
Helps you organize, track, and share your work in 1 place for teams and solo users.
A4M - American Academy of Anti-Aging Medicine
